Dec 2012

Liposomal amphotericin B as a treatment for human leishmaniasis

Expert Opinion on Emerging Drugs

by Balasegaram M, Ritmeijer K, Lima MA, Burza S, Ortiz Genovese G, Milani B, Gaspani S, Potet J, Chappuis F. Expert Opinion on Emerging Drugs, December 2012, Vol. 17, No. 4 , Pages 493-510

Click here to read the article / PDF

Latest scientific articles

Stay connected

Get our latest news, personal stories, research articles, and job opportunities.

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Liposomal amphotericin B as a treatment for human leishmaniasis

Latest scientific articles

Epidemiological, clinical and etiological treatment aspects in the Chagas clinic of the municipality of Comapa – Jutiapa, Guatemala

Quantitative analysis of DNDI-6174 using UPLC-MS/MS: A preclinical target site pharmacokinetic study

Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease

Efficient constitution of a library of rotenoid analogs active against Trypanosoma cruzi from a digitalized plant extract collection

Stay connected

Learn more

Get in touch

Support us

Work with us